The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.
about
Mutations, kataegis and translocations in B cells: understanding AID promiscuous activityRegulation of Aicda expression and AID activityThe APOBEC3 family of retroelement restriction factorsAID targeting: old mysteries and new challengesABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction.Generation and repair of AID-initiated DNA lesions in B lymphocytes.Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytesSelective induction of DNA repair pathways in human B cells activated by CD4+ T cellsTubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells.Chronic myeloid leukemia: mechanisms of blastic transformationActivation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.Complex regulation and function of activation-induced cytidine deaminase.Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.HSP90 inhibitors decrease AID levels and activity in mice and in human cells.AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemiaAIDing cancer treatment: Reducing AID activity via HSP90 inhibitionActivation-induced Cytidine Deaminase in B Cell Immunity and Cancers.CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.APOBEC3A damages the cellular genome during DNA replicationNucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase.APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.B cell-specific deficiencies in mTOR limit humoral immune responses.AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine.Activation induced deaminase C-terminal domain links DNA breaks to end protection and repair during class switch recombinationImatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway.A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia.The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential.Genetic mechanisms of chronic myeloid leukemia blastic transformation.The role of activation-induced deaminase in antibody diversification and genomic instability.Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
P2860
Q26768663-6DD461E0-7BE3-460B-A0F3-5DB5A7624163Q26853622-92036BE3-FD78-4E68-99C5-D086E74E6642Q26862780-9A9ED251-A32B-4A0A-84FD-416698173512Q28265992-25E7B977-AB6D-44CD-AD2C-17136D79A283Q30155948-7E420679-C32D-4A5B-9AB5-F1E81482F657Q33517413-76F61518-8FFD-4EE4-8761-8E3D8782CC49Q33654853-51E1E531-3DF7-4068-8D84-C95E72DA9C73Q33690522-9986D88F-FD53-4031-8280-05D9A770B57CQ33757410-32A5095A-CFE3-4BC5-880A-0C865271B999Q33778759-0F090834-F0B3-415B-8D03-8C4B503FE5CDQ33959401-0FF1DE9B-4CFB-46D9-A3C8-101F066F9510Q33968037-0C248DB6-D77E-44C5-BB1E-48D93604B0C5Q34168766-A0381336-9491-4A5E-A3DF-ADAB52700155Q34340626-335EFEE1-65FA-47FF-AD34-E7DA786B6B3CQ34750582-5E2B0DFE-A520-48CA-89F6-7F0EBDF33840Q34958445-63275EC5-84DF-4D5C-9622-0BBB29179B77Q35176062-54F52A82-663E-4E39-99AD-539C711BB190Q35182716-E9C82816-1354-445A-B76A-320AB08D8AE4Q35441406-367B92CF-718E-4B25-AA94-1D940E9F455BQ35669231-B48EB773-1AC3-4FAF-9A44-E4511686F23EQ35952172-3CA03F21-E0BB-4F74-AFAC-09608CA7651EQ36104522-1DCA2F2B-6383-4D10-BE9D-151800BB651CQ36157946-8B8ED203-C168-4E64-8A03-9D0F948459C6Q36194829-C392BC8E-901F-4AD6-A983-910A071600B0Q36367487-18B41995-9A7C-42EC-8301-253CCE626C75Q36592764-E93633C6-6562-4C91-A9B1-5A748015D951Q36891005-1A5073A9-EC9F-48AF-BB99-3EB5BDC677BFQ36956935-CD2D12E1-7315-4484-B1BD-9A16BFE33D74Q37143544-313DD88D-EAFB-4FE6-8E5E-31883008B16AQ37402303-CA4BE320-066C-41B7-B873-7AA5F06AA666Q37532105-21FD8478-A7FA-4C12-BDAC-DDC055B5B7BDQ37649663-16608C2F-AF03-4F85-9CD0-CC5481711E98Q37659903-0E2FA2E0-04BD-407C-BC8B-979258427BCEQ37729966-9120B356-CB48-4308-A9B9-3E1CEB642149Q37739072-B12AA39F-4EDA-48A6-BC5B-32A754F4A45FQ37743173-FF934BDC-E0FF-40A4-ACA9-708B968F6C01Q37946460-916BB7DA-2F0E-48E2-8CA3-4F34B41EEB8CQ37983490-3E622DBB-4BCA-4F62-92DC-39C5365BBAE0Q38041514-3A0321C3-401E-4652-A7BB-92CF5CB1A866Q38716411-E5179336-7A32-4DE2-A84A-425FFDFB1508
P2860
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@ast
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@en
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@nl
type
label
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@ast
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@en
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@nl
prefLabel
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@ast
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@en
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@nl
P2093
P2860
P50
P1433
P1476
The B cell mutator AID promote ...... e in chronic myeloid leukemia.
@en
P2093
Cihangir Duy
Gregor von Levetzow
Hassan Jumaa
John Groffen
Lars Klemm
Markus Müschen
Michael R Lieber
Nadine Henke
Nora Heisterkamp
Rafael Casellas
P2860
P304
P356
10.1016/J.CCR.2009.07.030
P577
2009-09-01T00:00:00Z